You are here: Industry Insights > research

News List

The discoveries made through ‘routine’ research can now be patentable europeanpharmaceuticalreview
April 02, 2019
In a ruling handed down on 27 March 2019 by the UK Supreme Court, Lord Hodge has confirmed that discoveries made through well-established or routine research protocols can be rewarded with a patent…
Discoveries made through ‘routine’ research can now be patentable europeanpharmaceuticalreview
March 29, 2019
In a ruling handed down on 27 March 2019 by the UK Supreme Court, Lord Hodge has confirmed that discoveries made through well-established or routine research protocols can be rewarded with a patent…
Scientists clarify what probiotics are and what they are not en-cphi.cn
March 15, 2019
A new scientific paper calls for strict adherence to the scientific definition, ensuring improper use of the term doesn't mislead consumers or limit advancements in the emerging field of microbiome science.
SPARC inks research collaboration pact with China’s HitGen expressbpd
March 13, 2019
Under the terms of the agreement, HitGen will receive upfront payment and will be eligible for certain milestone payments
Third Sartorius Research Xchange Forum 2019 Focuses on CAR-T Cell Therapy Friday, 08 March 2019 14:30 Hits: 769 分享 LinkedIn Twitter Google+ b3cnewswire
March 13, 2019
Promoting interdisciplinary exchange and fostering potential collaborations between academia and industry on highly promising scientific fields relevant to both scientists and businesses: this is the objective of Sartorius in hosting its third Research...
Pharma funding for neglected disease research hits record high europeanpharmaceuticalreview
January 28, 2019
Report shows consistent growth of the biopharmaceutical industry investment in neglected diseases…
Research on Almost 2,000 Brains Brings Insight Into Mental Illness drugs
December 14, 2018
Researchers say a massive genetic analysis of the human brain has yielded new insights into the underpinnings of psychiatric diseases such as schizophrenia, bipolar disorder and autism......
X4 Pharmaceuticals Presents Additional Positive Phase 2 Results for X4P-001 in WHIM Syndrome, Continues on Path to Initiation of Phase 3 Trial pharmafocusasia
December 03, 2018
X4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 allosteric antagonist drugs to improve immune cell trafficking to treat rare diseases and cancer...
Using graphene as a tunable ion filter europeanpharmaceuticalreview
November 28, 2018
NIST researchers have shown how graphene can be modified with pores and used as an ion filter, and could be adapted for use in drug delivery systems…
Some research may be encouraging ineffective prescriptions worldpharmanews
November 28, 2018
A new paper published by McGill University researchers in JAMA Internal Medicine suggests that some clinical trials may promote the use of ineffective and costly treatments.

Previous page 1 2 3 4 5 6 Next page